Mucoflux

Properties

The pharmacologically active substance in Mucoflux is sobrerol, a synthesis product from Rottapharm laboratories, which is chemically defined as follows:

D, L – trans – 1 – methyl – 4 – (2 – hydroxy – isopropyl) – cyclohex – 1, 2 – en – 6 -ol

The sobrerol reduces the viscosity of the mucus, favoring the expulsion of the mucous plugs from the respiratory tract, without affecting the alveolar surfactant or the ciliary movements of the bronchiotracheal mucosa and without bronchioconstrictor effects.

Thanks to these characteristics, its low general toxicity and good tolerance, sobrerol is an effective and safe substance in all those disorders where the respiratory tract is obstructed or overloaded by an excess of mucus that hinders the normal flow of air.

Mucoflux therefore performs two basic activities:

  1. Cleanser, since it allows and facilitates the removal of mucous and mucopurulent secretions.
  2. Eupnoic, since it improves respiratory parameters.

Indications

Mucoflux is indicated in:

Acute and chronic disorders of the respiratory system, with increased or stagnant bronchial secretion.

Acute and chronic bronchitis, bronchiolitis, bronchopneumonia, particularly if associated with asthma, emphysema, bronchiectasis.

Pulmonary manifestations of cystic fibrosis.

Rhinopharyngitis, acute and chronic laryngotracheitis, sinusitis, pre- and post-operative cleansing treatments for the respiratory system.

Mucoflux can be safely combined with antibiotics.


Pharmacological interactions

So far, no drug interactions have been verified.

Contraindications

So far no contraindications have been verified.

Side Effects

No significant local or systemic adverse effects have been found so far.

Cautions

Mucoflux lacks any mutagenic or teratogenic effect. However, its administration to pregnant women should be carried out only if strictly necessary and under medical supervision.

Patients with kidney failure should be under medical supervision during treatment with Mucoflux.

Leave out of the reach of children!

Composition

Sobrerol 0.8%


Administration 

 

Oral


Posology

Adults:

Mucoflux Syrup: 1-2 measures (10-20 ml) 2 times a day.

Mucoflux Capsules: 2 capsules 2 times a day for 2 weeks or more, according to medical prescription.

Children over 2 years old:

Mucoflux Syrup: 1 measure (10 ml) 2 times a day.

Children under 2 years old:

Mucoflux Syrup: 1/2 measure (5 ml) 2 times a day.


Presentation

Mucoflux syrup: bottle with 150 ml of syrup, containing 80 mg of sobrerol per measure (10 ml).